-
1 Comment
Concepta PLC is currently in a long term uptrend where the price is trading 52.6% above its 200 day moving average.
From a valuation standpoint, the stock is 58.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 184.0.
Based on the above factors, Concepta PLC gets an overall score of 2/5.
Exchange | LSE |
---|---|
CurrencyCode | GBP |
ISIN | GB00BYZ2R301 |
Sector | Healthcare |
Industry | Medical Devices |
Market Cap | 10M |
---|---|
PE Ratio | None |
Target Price | 22 |
Dividend Yield | 0.0% |
Beta | 2.07 |
Concepta PLC, a women's healthcare company, develops and commercializes mobile health diagnostics medical devices in the United Kingdom. Its products help women with unexplained infertility to concieve. The company offers MYLO, a home-use personalized fertility tracking and pregnancy self-testing system. MYLO allows quantitative and qualitative home (self-test) test measurement of a woman's personal luteinizing hormone during ovulation and human chorionic gonadotropin hormone level during pregnancy, facilitating conception rates and early diagnosis of fertility issues. The company was formerly known as Frontier Resources International PLC. Concepta PLC was incorporated in 2008 and is based in Cardiff, the United Kingdom.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CPT.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025